As Check-Cap starts its clinical trial for CE Mark on its prep-free C-Scan imaging capsule for colorectal cancer screening, the company’s CEO discusses the technology’s potential.
Good news for—well, all of us. Check-Cap’s C-Scan system for colorectal cancer screening without the need for a bowel prep is ready to enter the clinical performance phase of development.
After being swallowed in capsule form, the C-Scan system’s ultra-low-dose X-ray technology is used to produce a 3-D map of a patient’s colon. The system differs from capsule technology already on the market by eliminating the need for a bowel prep prior to ingestion and examining the colon in its natural state without distention.
In January, ...